Savara Depreciation & Amortization 2011-2026 | SVRA

Annual Depreciation & Amortization Savara

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996
87 K	130 K	77 K	31 K	136 K	255 K	1.01 M	526 K	363 K	99 K	146 K	85 K	39.5 K	90 K	37.6 K	19.8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.01 M	19.8 K	196 K

Quarterly Depreciation & Amortization Savara

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
24 K	36 K	34 K	30 K	-	33 K	33 K	32 K	-	30 K	8 K	8 K	-	8 K	8 K	8 K	-	40 K	47 K	47 K	-	63 K	68 K	242 K	-	56 K	539 K	307 K	-	387 K	260 K	107 K	-	91 K	91 K	11 K	-	24 K	30 K	32 K	-	38 K	37 K	30 K	-	25 K	23 K	11.4 K	-	10.1 K	8.88 K	9.8 K	-	77.6 K	66.9 K	30.2 K	-	8.5 K	10.4 K	9.87 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
539 K	8 K	68.1 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Esperion Therapeutics ESPR	105 K	$ 3.14	0.16 %	$ 653 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 34.42	4.65 %	$ 926 M	USA
Forte Biosciences FBRX	64 K	$ 20.35	1.4 %	$ 263 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 6.84	2.17 %	$ 187 M	Israel
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.64	0.61 %	$ 436 M	Britain
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	2.31 M	$ 0.85	0.57 %	$ 142 M	USA
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	475 K	$ 2.74	0.18 %	$ 256 M	Israel
Anika Therapeutics ANIK	5.37 M	$ 15.15	2.23 %	$ 217 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.39	4.17 %	$ 5.58 M	Israel
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.52	2.7 %	$ 178 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 20.45	4.9 %	$ 2.6 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA